STANNOUS FLUORIDE

STANNOUS FLUORIDE was reported 721 times

STANNOUS FLUORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NANOPARTICLE TOXICITY 1 0.5000
1 ACCIDENTAL DEVICE INGESTION BY A CHILD 2 0.4000
2 VERTEBRAL LATERAL RECESS STENOSIS 6 0.3158
3 LIGAMENTUM FLAVUM HYPERTROPHY 6 0.1304
4 CORROSIVE OROPHARYNGEAL INJURY 3 0.0968
5 ACCIDENTAL DEVICE INGESTION 4 0.0909
6 OSTEOARTHROPATHY 6 0.0822
7 CHEMICAL BURN OF GASTROINTESTINAL TRACT 10 0.0730
8 AXILLARY WEB SYNDROME 1 0.0476
9 CHEMICAL BURN OF ORAL CAVITY 2 0.0455
10 BURN ORAL CAVITY 21 0.0365
11 GINGIVAL DISCOMFORT 24 0.0363
12 DEVICE USED FOR UNAPPROVED SCHEDULE 1 0.0345
13 ADMINISTRATION SITE HYPERSENSITIVITY 1 0.0323
14 WATER POLLUTION 1 0.0238
15 ORAL MUCOSAL ROUGHENING 2 0.0235
16 SALIVARY GLAND MUCOCOELE 1 0.0227
17 ORAL MUCOSAL EXFOLIATION 34 0.0225
18 UVULITIS 2 0.0194
19 HYPERAESTHESIA TEETH 22 0.0174
20 ISCHAEMIC ULCER 1 0.0167
21 DENTAL PARAESTHESIA 1 0.0164
22 REACTION TO FOOD ADDITIVE 2 0.0148
23 LOW DENSITY LIPOPROTEIN 1 0.0147
24 MISOPHONIA 1 0.0147
25 CHEMICAL BURN OF RESPIRATORY TRACT 1 0.0128
26 LIP ERYTHEMA 10 0.0125
27 GINGIVAL EROSION 3 0.0116
28 ORAL BACTERIAL INFECTION 2 0.0110
29 TOOTH DISCOLOURATION 32 0.0109
30 NONINFECTIVE GINGIVITIS 15 0.0104
31 TOOTH DEMINERALISATION 1 0.0095
32 SPINAL SYNOVIAL CYST 1 0.0095
33 NECROTISING ULCERATIVE GINGIVOSTOMATITIS 1 0.0094
34 GINGIVAL BLISTER 4 0.0091
35 ORAL CONTUSION 2 0.0087
36 TONGUE EXFOLIATION 3 0.0085
37 RECTAL OBSTRUCTION 1 0.0085
38 DENTAL DISCOMFORT 7 0.0083
39 HYPERTROPHY OF TONGUE PAPILLAE 1 0.0083
40 DENTAL CYST 1 0.0081
41 GINGIVAL ERYTHEMA 7 0.0081
42 TOE OPERATION 6 0.0076
43 COATING IN MOUTH 4 0.0075
44 ORAL DISCOMFORT 101 0.0073
45 DENTAL PLAQUE 2 0.0072
46 ORAL MUCOSAL ERYTHEMA 10 0.0065
47 SENSITIVITY OF TEETH 11 0.0064
48 LIP PAIN 18 0.0063
49 SALIVARY HYPOSECRETION 1 0.0062
50 GINGIVAL OEDEMA 1 0.0057
51 GINGIVAL DISCOLOURATION 3 0.0056
52 TONGUE BLISTERING 12 0.0054
53 GINGIVAL INFLAMMATION 1 0.0053
54 GINGIVAL PAIN 42 0.0053
55 GINGIVAL ATROPHY 1 0.0051
56 TONGUE DISCOMFORT 21 0.0049
57 CHEMICAL INJURY 4 0.0049
58 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
59 PRODUCT ADVERTISING ISSUE 1 0.0047
60 LIP EXFOLIATION 6 0.0045
61 ANGINA BULLOSA HAEMORRHAGICA 1 0.0043
62 APPLICATION SITE HYPOAESTHESIA 1 0.0043
63 GINGIVAL DISORDER 16 0.0042
64 PALATAL SWELLING 1 0.0041
65 GINGIVAL INJURY 1 0.0041
66 TONGUE GEOGRAPHIC 1 0.0040
67 GINGIVAL SWELLING 17 0.0038
68 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
69 CHEILITIS 20 0.0037
70 TONGUE DRY 5 0.0037
71 TONGUE ERYTHEMA 3 0.0036
72 IDIOPATHIC PNEUMONIA SYNDROME 1 0.0034
73 TRANSFUSION-RELATED ACUTE LUNG INJURY 1 0.0032
74 ORAL MUCOSAL DISCOLOURATION 2 0.0030
75 TOOTH DEPOSIT 1 0.0029
76 ORAL DISCHARGE 1 0.0027
77 SINUS PAIN 6 0.0026
78 TOOTHACHE 46 0.0025
79 GLOSSITIS 9 0.0025
80 OROPHARYNGEAL PLAQUE 1 0.0025
81 PHARYNGEAL HAEMORRHAGE 3 0.0024
82 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
83 TONGUE ULCERATION 8 0.0024
84 TONGUE MOVEMENT DISTURBANCE 2 0.0023
85 ORAL PAIN 52 0.0023
86 TONGUE DISCOLOURATION 10 0.0023
87 ENLARGED UVULA 1 0.0022
88 HERNIA PAIN 1 0.0022
89 BILIARY TRACT DISORDER 3 0.0022
90 METAPLASIA 1 0.0021
91 LIP DISORDER 4 0.0021
92 MOUTH SWELLING 12 0.0021
93 DRAINAGE 1 0.0020
94 TONGUE ERUPTION 1 0.0020
95 PHARYNGEAL ABSCESS 1 0.0020
96 EXPOSURE VIA INGESTION 5 0.0020
97 MOUTH INJURY 3 0.0020
98 HERPES ZOSTER OTICUS 1 0.0020
99 INJURY CORNEAL 1 0.0019
100 SALIVARY GLAND ENLARGEMENT 1 0.0019
101 OROPHARYNGEAL BLISTERING 3 0.0018
102 RHINALGIA 5 0.0018
103 APHTHOUS ULCER 14 0.0018
104 ORAL DISORDER 13 0.0018
105 CHEMICAL BURN 2 0.0017
106 TRICHOTILLOMANIA 1 0.0017
107 IRREGULAR BREATHING 1 0.0017
108 HYPOAESTHESIA EYE 1 0.0017
109 ENGRAFTMENT SYNDROME 1 0.0017
110 GRUNTING 1 0.0017
111 HYPOAESTHESIA ORAL 25 0.0017
112 PALATAL DISORDER 1 0.0017
113 TOOTH INJURY 7 0.0016
114 LIP DRY 14 0.0015
115 LIP INJURY 2 0.0015
116 VICTIM OF CHEMICAL SUBMISSION 1 0.0015
117 EMERGENCY CARE EXAMINATION 1 0.0015
118 LIP BLISTER 4 0.0015
119 SPINAL STENOSIS 6 0.0015
120 ANGULAR CHEILITIS 1 0.0014
121 APPLICATION SITE ULCER 1 0.0014
122 DRUG-DISEASE INTERACTION 1 0.0014
123 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
124 GINGIVAL ULCERATION 1 0.0013
125 GINGIVAL BLEEDING 18 0.0013
126 ORAL PRURITUS 3 0.0013
127 ORAL MUCOSAL ERUPTION 2 0.0013
128 GLOSSODYNIA 29 0.0013
129 DEVICE DAMAGE 1 0.0013
130 TONGUE DISORDER 9 0.0012
131 EXCESSIVE GRANULATION TISSUE 1 0.0012
132 VERTEBRAL FORAMINAL STENOSIS 1 0.0012
133 APTYALISM 1 0.0012
134 LIP PRURITUS 1 0.0012
135 AGEUSIA 29 0.0012
136 CHAPPED LIPS 5 0.0012
137 SALIVA ALTERED 1 0.0011
138 SKIN GRAFT 1 0.0011
139 PHARYNGEAL HYPOAESTHESIA 1 0.0011
140 TONGUE INJURY 1 0.0011
141 LIP SWELLING 34 0.0010
142 FOAMING AT MOUTH 2 0.0010
143 LIP ULCERATION 1 0.0009
144 TONGUE HAEMORRHAGE 1 0.0009
145 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
146 PARAESTHESIA ORAL 12 0.0008
147 TOOTH EROSION 1 0.0008
148 LIP DISCOLOURATION 1 0.0008
149 MALLORY-WEISS SYNDROME 1 0.0008
150 LIP HAEMORRHAGE 1 0.0008
151 DACRYOSTENOSIS ACQUIRED 1 0.0008
152 PRODUCT FORMULATION ISSUE 5 0.0008
153 PHARYNGEAL ULCERATION 1 0.0008
154 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
155 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 5 0.0007
156 CORNEAL OPACITY 1 0.0007
157 ABSCESS ORAL 1 0.0007
158 CHOKING 14 0.0007
159 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 21 0.0007
160 STOMATITIS 43 0.0007
161 DERMATITIS CONTACT 8 0.0007
162 SPINAL OSTEOARTHRITIS 6 0.0007
163 MOUTH HAEMORRHAGE 5 0.0007
164 MASTICATION DISORDER 2 0.0007
165 COAGULATION TIME PROLONGED 1 0.0006
166 PRODUCT COMPLAINT 16 0.0006
167 PHARYNGEAL PARAESTHESIA 1 0.0006
168 TOTAL LUNG CAPACITY DECREASED 1 0.0006
169 LOOSE TOOTH 2 0.0006
170 OEDEMA MOUTH 2 0.0006
171 INTESTINAL POLYP 1 0.0006
172 ORAL CANDIDIASIS 8 0.0006
173 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
174 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
175 TONGUE COATED 1 0.0006
176 MOUTH ULCERATION 12 0.0006
177 OPHTHALMIC HERPES ZOSTER 1 0.0006
178 SWOLLEN TONGUE 17 0.0005
179 TOOTH FRACTURE 6 0.0005
180 DENTAL CARIES 6 0.0005
181 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
182 DYSENTERY 1 0.0005
183 TOOTH LOSS 11 0.0005
184 PANCREATIC CYST 1 0.0005
185 HYPOGEUSIA 1 0.0005
186 SUSPECTED COUNTERFEIT PRODUCT 2 0.0005
187 TONGUE BITING 1 0.0005
188 REACTION TO DRUG EXCIPIENTS 1 0.0005
189 TOOTH DISORDER 10 0.0004
190 CORNEAL OEDEMA 1 0.0004
191 APHTHOUS STOMATITIS 1 0.0004
192 LICHEN PLANUS 1 0.0004
193 ORAL SURGERY 1 0.0004
194 THERMAL BURN 3 0.0004
195 PRODUCT PACKAGING CONFUSION 1 0.0004
196 BREATH ODOUR 1 0.0004
197 PHARYNGEAL SWELLING 4 0.0004
198 THROAT IRRITATION 18 0.0004
199 FEEDING DISORDER 8 0.0004
200 ENDODONTIC PROCEDURE 1 0.0004
201 DYSGEUSIA 29 0.0004
202 PHARYNGEAL OEDEMA 6 0.0004
203 BLOOD CHLORIDE DECREASED 1 0.0004
204 CATHETER SITE PAIN 1 0.0004
205 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
206 PRODUCT TASTE ABNORMAL 5 0.0004
207 TYPE IV HYPERSENSITIVITY REACTION 1 0.0004
208 EAR PAIN 7 0.0004
209 SKIN HYPERTROPHY 1 0.0004
210 OESOPHAGEAL STENOSIS 1 0.0004
211 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
212 FIBROSIS 1 0.0003
213 TOOTH EXTRACTION 4 0.0003
214 FOREIGN BODY IN THROAT 1 0.0003
215 SNEEZING 7 0.0003
216 FACET JOINT SYNDROME 1 0.0003
217 METASTASES TO LYMPH NODES 2 0.0003
218 TOOTH ABSCESS 3 0.0003
219 APPLICATION SITE DRYNESS 1 0.0003
220 BRONCHOPNEUMONIA 1 0.0003
221 EAR PRURITUS 1 0.0003
222 KNEE ARTHROPLASTY 6 0.0003
223 APPLICATION SITE REACTION 2 0.0003
224 FACIAL PARESIS 1 0.0003
225 GRAFT VERSUS HOST DISEASE 2 0.0003
226 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
227 DRY MOUTH 22 0.0003
228 SNORING 1 0.0003
229 PARANASAL SINUS DISCOMFORT 1 0.0003
230 OESOPHAGEAL DISORDER 1 0.0003
231 THROAT TIGHTNESS 7 0.0003
232 OESOPHAGEAL PAIN 1 0.0003
233 FOREIGN BODY 1 0.0002
234 EXPIRED PRODUCT ADMINISTERED 8 0.0002
235 HYPERPYREXIA 1 0.0002
236 FACIAL PARALYSIS 2 0.0002
237 INTENTIONAL DEVICE MISUSE 1 0.0002
238 ACUTE GRAFT VERSUS HOST DISEASE 1 0.0002
239 AUTOIMMUNE DISORDER 2 0.0002
240 INCORRECT DOSAGE ADMINISTERED 1 0.0002
241 COELIAC DISEASE 2 0.0002
242 EXPIRED DRUG ADMINISTERED 1 0.0002
243 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
244 APPLICATION SITE SWELLING 1 0.0002
245 PROTEIN URINE PRESENT 1 0.0002
246 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
247 TASTE DISORDER 4 0.0002
248 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
249 FOETAL DEATH 1 0.0002
250 EYE DISCHARGE 2 0.0002
251 LEARNING DISABILITY 1 0.0002
252 RETCHING 4 0.0002
253 FOOD POISONING 1 0.0002
254 GINGIVITIS 1 0.0002
255 APPLICATION SITE PAIN 4 0.0002
256 ANAPHYLACTIC REACTION 10 0.0002
257 PERIORBITAL SWELLING 1 0.0002
258 PAIN IN JAW 5 0.0002
259 ELECTROLYTE IMBALANCE 2 0.0002
260 DYSPHONIA 10 0.0002
261 HYPERCHLORHYDRIA 1 0.0002
262 ODYNOPHAGIA 1 0.0002
263 MACULAR DEGENERATION 2 0.0002
264 SYMPTOM RECURRENCE 1 0.0002
265 LARYNGEAL OEDEMA 1 0.0002
266 SCOLIOSIS 1 0.0002
267 CYST 2 0.0002
268 BACTERIAL INFECTION 3 0.0002
269 APPLICATION SITE IRRITATION 2 0.0002
270 SWELLING OF EYELID 1 0.0002
271 POISONING 2 0.0002
272 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
273 MYDRIASIS 2 0.0002
274 SWELLING FACE 10 0.0002
275 TERMINAL STATE 1 0.0001
276 HYPERSENSITIVITY 27 0.0001
277 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
278 RESPIRATION ABNORMAL 1 0.0001
279 LARGE INTESTINE PERFORATION 1 0.0001
280 DUODENAL ULCER 1 0.0001
281 HAND FRACTURE 1 0.0001
282 EATING DISORDER 3 0.0001
283 OROPHARYNGEAL PAIN 13 0.0001
284 BRONCHOSPASM 2 0.0001
285 RHINORRHOEA 9 0.0001
286 ANOSMIA 2 0.0001
287 DYSPHAGIA 13 0.0001
288 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
289 TROPONIN INCREASED 1 0.0001
290 BOWEL MOVEMENT IRREGULARITY 1 0.0001
291 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
292 TENDONITIS 2 0.0001
293 BURNING SENSATION 9 0.0001
294 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
295 NASAL DISCOMFORT 1 0.0001
296 BLOOD ALBUMIN DECREASED 1 0.0001
297 SENSORY LOSS 1 0.0001
298 RHINITIS 1 0.0001
299 FRUSTRATION TOLERANCE DECREASED 1 0.0001
300 HYPERAESTHESIA 1 0.0001
301 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
302 HAIR DISORDER 1 0.0001
303 MUSCLE INJURY 1 0.0001
304 SENSATION OF FOREIGN BODY 1 0.0001
305 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
306 ANAPHYLACTIC SHOCK 3 0.0001
307 MUSCLE STRAIN 1 0.0001
308 LOCAL SWELLING 2 0.0001
309 GROIN PAIN 1 0.0001
310 PRODUCT USE IN UNAPPROVED INDICATION 28 0.0001
311 FACIAL PAIN 1 0.0001
312 ANAL INCONTINENCE 1 0.0001
313 OROPHARYNGEAL DISCOMFORT 1 0.0001
314 MIDDLE INSOMNIA 2 0.0001
315 BLISTER 6 0.0001
316 SQUAMOUS CELL CARCINOMA 1 0.0001
317 BLOOD URINE PRESENT 2 0.0001
318 EYE INFLAMMATION 1 0.0001
319 ORAL HERPES 2 0.0001
320 NASAL CONGESTION 6 0.0001
321 CONDITION AGGRAVATED 31 0.0001
322 HYPOTONIA 1 0.0001
323 BRAIN INJURY 1 0.0001
324 ILL-DEFINED DISORDER 6 0.0001
325 EAR DISCOMFORT 1 0.0001
326 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
327 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
328 SCRATCH 1 0.0001
329 PHARYNGITIS STREPTOCOCCAL 1 0.0001
330 SKIN LACERATION 1 0.0001
331 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
332 ANGIOEDEMA 4 0.0001
333 MALNUTRITION 1 0.0001
334 BLOOD CALCIUM DECREASED 1 0.0001
335 INTERNAL HAEMORRHAGE 1 0.0001
336 MYOCARDITIS 1 0.0001
337 NEOPLASM 1 0.0001
338 COVID-19 PNEUMONIA 1 0.0001
339 LOCALISED INFECTION 2 0.0001
340 ADRENAL INSUFFICIENCY 1 0.0001
341 NOCTURIA 1 0.0001
342 NEURALGIA 2 0.0001
343 DYSPEPSIA 8 0.0001
344 PEMPHIGUS 1 0.0001
345 SECRETION DISCHARGE 1 0.0001
346 INTRAOCULAR PRESSURE INCREASED 1 0.0001
347 ADVERSE DRUG REACTION 7 0.0001
348 SPEECH DISORDER 4 0.0001
349 BEDRIDDEN 1 0.0001
350 IMMUNE SYSTEM DISORDER 1 0.0001
351 TOOTH INFECTION 1 0.0001
352 BLOOD BILIRUBIN INCREASED 2 0.0001
353 BLINDNESS 3 0.0001
354 TACHYPNOEA 1 0.0001
355 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 13 0.0001
356 HAEMOPTYSIS 2 0.0001
357 WOUND 2 0.0001
358 COUGH 20 0.0001
359 BLINDNESS UNILATERAL 1 0.0001
360 SEASONAL ALLERGY 1 0.0001
361 SINUS TACHYCARDIA 1 0.0001
362 SINUSITIS 7 0.0001
363 BONE LOSS 1 0.0001
364 PRODUCT QUALITY ISSUE 9 0.0001
365 APHASIA 2 0.0001
366 THYROID DISORDER 1 0.0001
367 LIMB DISCOMFORT 2 0.0001
368 SWELLING 6 0.0001
369 PRODUCT USE COMPLAINT 1 0.0001
370 ULCER 1 0.0001
371 SENSORY DISTURBANCE 1 0.0001
372 NIGHT SWEATS 2 0.0001
373 DRUG INEFFECTIVE 80 0.0001
374 PERICARDITIS 1 0.0001
375 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
376 FACE OEDEMA 1 0.0001
377 SKIN EXFOLIATION 5 0.0001
378 CANDIDA INFECTION 1 0.0001
379 HAEMORRHAGE 6 0.0001
380 PARAESTHESIA 9 0.0001
381 DEVICE USE ISSUE 1 0.0001
382 LYMPHADENOPATHY 2 0.0001
383 THIRST 1 0.0001
384 RASH PRURITIC 3 0.0001
385 CONJUNCTIVITIS 1 0.0001
386 BLOOD SODIUM DECREASED 1 0.0001
387 GASTRIC ULCER 1 0.0001
388 SLEEP APNOEA SYNDROME 1 0.0001
389 PULMONARY FIBROSIS 1 0.0001
390 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
391 PERIPHERAL SWELLING 8 0.0001
392 DYSTONIA 1 0.0001
393 JOINT SWELLING 6 0.0000
394 PRODUCT PHYSICAL ISSUE 1 0.0000
395 DISCOMFORT 3 0.0000
396 NASOPHARYNGITIS 9 0.0000
397 DERMATITIS 1 0.0000
398 RENAL FAILURE ACUTE 2 0.0000
399 IMPAIRED WORK ABILITY 1 0.0000
400 HYPOAESTHESIA 7 0.0000
401 PRURITUS GENERALISED 1 0.0000
402 MENTAL DISORDER 2 0.0000
403 TRANSAMINASES INCREASED 1 0.0000
404 RASH MACULO-PAPULAR 1 0.0000
405 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
406 PRODUCT AVAILABILITY ISSUE 1 0.0000
407 SKIN IRRITATION 2 0.0000
408 HYPOKALAEMIA 2 0.0000
409 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
410 LIVER INJURY 1 0.0000
411 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
412 COVID-19 7 0.0000
413 HYPOPHAGIA 1 0.0000
414 ERECTILE DYSFUNCTION 1 0.0000
415 ERYTHEMA 8 0.0000
416 ILLNESS 4 0.0000
417 RASH GENERALISED 1 0.0000
418 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
419 MUCOSAL INFLAMMATION 1 0.0000
420 APPLICATION SITE ERYTHEMA 1 0.0000
421 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
422 PLATELET COUNT DECREASED 4 0.0000
423 BREAST CANCER FEMALE 1 0.0000
424 FEAR 1 0.0000
425 DISTURBANCE IN ATTENTION 2 0.0000
426 LIMB INJURY 1 0.0000
427 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
428 DIVERTICULITIS 1 0.0000
429 PROCEDURAL PAIN 1 0.0000
430 NECK PAIN 2 0.0000
431 DEMENTIA 1 0.0000
432 HYPONATRAEMIA 2 0.0000
433 EYE IRRITATION 2 0.0000
434 DYSSTASIA 1 0.0000
435 LABORATORY TEST ABNORMAL 1 0.0000
436 URINARY INCONTINENCE 1 0.0000
437 LACRIMATION INCREASED 1 0.0000
438 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
439 EXPOSURE DURING PREGNANCY 2 0.0000
440 NERVOUS SYSTEM DISORDER 1 0.0000
441 DYSPNOEA 18 0.0000
442 MIGRAINE 3 0.0000
443 HYPOTHYROIDISM 1 0.0000
444 DRUG DEPENDENCE 5 0.0000
445 OSTEONECROSIS 1 0.0000
446 EYE DISORDER 1 0.0000
447 VIRAL INFECTION 1 0.0000
448 DEHYDRATION 4 0.0000
449 SYNCOPE 3 0.0000
450 URINARY RETENTION 1 0.0000
451 DRY SKIN 4 0.0000
452 ABDOMINAL DISCOMFORT 5 0.0000
453 ANGER 1 0.0000
454 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
455 GASTRIC DISORDER 1 0.0000
456 DEVICE USE ERROR 1 0.0000
457 INJURY 2 0.0000
458 SLEEP DISORDER 2 0.0000
459 CEREBRAL HAEMORRHAGE 1 0.0000
460 DRUG EFFECT INCOMPLETE 1 0.0000
461 CRYING 1 0.0000
462 C-REACTIVE PROTEIN INCREASED 1 0.0000
463 MALAISE 12 0.0000
464 ACCIDENTAL OVERDOSE 1 0.0000
465 PAIN IN EXTREMITY 8 0.0000
466 SEPSIS 3 0.0000
467 EYE SWELLING 1 0.0000
468 DYSARTHRIA 1 0.0000
469 HOT FLUSH 2 0.0000
470 UNEVALUABLE EVENT 2 0.0000
471 SEIZURE 3 0.0000
472 BACK PAIN 6 0.0000
473 WEIGHT DECREASED 7 0.0000
474 ABORTION SPONTANEOUS 1 0.0000
475 THROMBOSIS 2 0.0000
476 PNEUMONIA 8 0.0000
477 DYSKINESIA 1 0.0000
478 NEUTROPHIL COUNT DECREASED 1 0.0000
479 PAIN 15 0.0000
480 URTICARIA 4 0.0000
481 OSTEOARTHRITIS 1 0.0000
482 LOSS OF CONSCIOUSNESS 3 0.0000
483 HYPOACUSIS 1 0.0000
484 DEVICE LEAKAGE 1 0.0000
485 DEVICE DISLOCATION 1 0.0000
486 INSOMNIA 6 0.0000
487 GASTROINTESTINAL DISORDER 2 0.0000
488 MEMORY IMPAIRMENT 3 0.0000
489 ADVERSE EVENT 2 0.0000
490 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
491 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
492 PRODUCT USE ISSUE 4 0.0000
493 PULMONARY EMBOLISM 2 0.0000
494 NEUROPATHY PERIPHERAL 2 0.0000
495 DISEASE RECURRENCE 1 0.0000
496 COMA 1 0.0000
497 RENAL CANCER 1 0.0000
498 ANAEMIA 4 0.0000
499 PRODUCTIVE COUGH 1 0.0000
500 RASH ERYTHEMATOUS 1 0.0000
501 FEELING ABNORMAL 5 0.0000
502 ATRIAL FIBRILLATION 2 0.0000
503 LUNG DISORDER 1 0.0000
504 CELLULITIS 1 0.0000
505 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
506 INFLAMMATION 1 0.0000
507 ARTHRALGIA 8 0.0000
508 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
509 ABDOMINAL DISTENSION 2 0.0000
510 VOMITING 9 0.0000
511 DEPRESSED MOOD 1 0.0000
512 OEDEMA 1 0.0000
513 RASH 8 0.0000
514 INFLUENZA 2 0.0000
515 OXYGEN SATURATION DECREASED 1 0.0000
516 EYE PAIN 1 0.0000
517 URINARY TRACT INFECTION 3 0.0000
518 CONVULSION 1 0.0000
519 HERPES ZOSTER 1 0.0000
520 LETHARGY 1 0.0000
521 PRODUCT SUBSTITUTION ISSUE 1 0.0000
522 WHEEZING 1 0.0000
523 CATARACT 1 0.0000
524 THERAPEUTIC RESPONSE DECREASED 1 0.0000
525 PLEURAL EFFUSION 1 0.0000
526 VERTIGO 1 0.0000
527 FEELING HOT 1 0.0000
528 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
529 VISUAL IMPAIRMENT 2 0.0000
530 GAIT DISTURBANCE 3 0.0000
531 PRURITUS 6 0.0000
532 DEEP VEIN THROMBOSIS 1 0.0000
533 AMNESIA 1 0.0000
534 PRODUCT DOSE OMISSION 1 0.0000
535 NAUSEA 12 0.0000
536 INFUSION RELATED REACTION 1 0.0000
537 NEOPLASM MALIGNANT 1 0.0000
538 ABDOMINAL PAIN UPPER 3 0.0000
539 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
540 SKIN BURNING SENSATION 1 0.0000
541 RESPIRATORY FAILURE 1 0.0000
542 AGITATION 1 0.0000
543 WEIGHT INCREASED 3 0.0000
544 EPISTAXIS 1 0.0000
545 DEPRESSION 3 0.0000
546 DIABETES MELLITUS 1 0.0000
547 BLOOD PRESSURE INCREASED 2 0.0000
548 HOSPITALISATION 2 0.0000
549 FATIGUE 10 0.0000
550 ARTHRITIS 1 0.0000
551 INJECTION SITE HAEMORRHAGE 1 0.0000
552 CARDIAC FAILURE CONGESTIVE 1 0.0000
553 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
554 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
555 BALANCE DISORDER 1 0.0000
556 PRODUCT STORAGE ERROR 1 0.0000
557 INTENTIONAL PRODUCT MISUSE 1 0.0000
558 MUSCULOSKELETAL STIFFNESS 1 0.0000
559 TACHYCARDIA 1 0.0000
560 MUSCLE SPASMS 2 0.0000
561 CHEST PAIN 2 0.0000
562 ASTHENIA 4 0.0000
563 DRUG INTOLERANCE 1 0.0000
564 OFF LABEL USE 9 0.0000
565 ALOPECIA 2 0.0000
566 HEART RATE INCREASED 1 0.0000
567 SOMNOLENCE 2 0.0000
568 CHEST DISCOMFORT 1 0.0000
569 HAEMOGLOBIN DECREASED 1 0.0000
570 HEADACHE 6 0.0000
571 DIARRHOEA 6 0.0000
572 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
573 CONSTIPATION 2 0.0000
574 FALL 3 0.0000
575 THROMBOCYTOPENIA 1 0.0000
576 ASTHMA 1 0.0000
577 RHEUMATOID ARTHRITIS 1 0.0000
578 MUSCULAR WEAKNESS 1 0.0000
579 PYREXIA 3 0.0000
580 PALPITATIONS 1 0.0000
581 EMOTIONAL DISTRESS 1 0.0000
582 OEDEMA PERIPHERAL 1 0.0000
583 PSORIASIS 1 0.0000
584 RENAL FAILURE 1 0.0000
585 NEUTROPENIA 1 0.0000
586 VISION BLURRED 1 0.0000
587 ANXIETY 2 0.0000
588 DEATH 6 0.0000
589 TREMOR 1 0.0000
590 TOXICITY TO VARIOUS AGENTS 1 0.0000
591 CEREBROVASCULAR ACCIDENT 1 0.0000
592 MYOCARDIAL INFARCTION 1 0.0000
593 BLOOD GLUCOSE INCREASED 1 0.0000
594 HYPOTENSION 1 0.0000
595 OVERDOSE 1 0.0000
596 DIZZINESS 1 0.0000